Screener
LivaNova LIVN Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by LivaNova in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: LivaNova’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 2:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001639691-26-000090
FAQ
- What is LivaNova's cash & equivalents?
- LivaNova (LIVN) reported cash & equivalents of $516.62M in Q2 2026.
- How has LivaNova's cash & equivalents changed year-over-year?
- LivaNova's cash & equivalents decreased by 13.0% year-over-year, from $593.64M to $516.62M.
- What is the long-term trend for LivaNova's cash & equivalents?
- Over 5 years (2020 to 2025), LivaNova's cash & equivalents has grown at a 20.2% compound annual growth rate (CAGR), from $252.83M to $635.55M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about LivaNova's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude